当前位置:首页 - 行情中心 - 朗威股份(301202) - 财务分析 - 利润表

朗威股份

(301202)

  

流通市值:29.74亿  总市值:50.95亿
流通股本:7961.75万   总股本:1.36亿

利润表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、营业总收入843,405,626.23313,900,459.771,252,561,338.27902,509,458.38
  营业收入843,405,626.23313,900,459.771,252,561,338.27902,509,458.38
二、营业总成本779,222,244.56290,340,982.711,189,740,876.42855,115,231.28
  营业成本687,425,386.43250,248,374.821,029,054,831.97737,516,902.35
  税金及附加7,095,312.263,226,865.3611,266,270.358,054,945.25
  销售费用31,969,441.1713,851,220.2255,197,162.6140,488,072.3
  管理费用27,635,190.0412,597,688.847,585,163.9435,223,229.96
  研发费用21,405,820.39,820,401.3344,231,969.5933,462,036.82
  财务费用3,691,094.36596,432.182,405,477.96370,044.6
  其中:利息费用3,240,745.941,334,527.116,708,591.495,310,526.4
  其中:利息收入3,850,329.672,493,416.893,404,950.713,227,449.41
三、其他经营收益
  加:投资收益10,637.86194,314.613,626,999.22,889,659.13
  资产处置收益254,840.1228,463-366,284.52-462,582.5
  资产减值损失(新)-5,114,273.95-3,175,021.41-9,064,634.58-7,220,305.18
  信用减值损失(新)-11,025,423.47-1,487,441.333,256,539.226,006,094.46
  其他收益2,535,348.991,434,492.7415,273,112.0513,462,542.13
四、营业利润50,844,511.220,754,284.6775,546,193.2262,069,635.14
  加:营业外收入6,258.83,256.86619,855.61491,594.94
  减:营业外支出1,887,393.981,322.54967,036.19556,726.99
五、利润总额48,963,376.0220,756,218.9975,199,012.6462,004,503.09
  减:所得税费用13,337,159.413,062,798.658,176,923.976,023,850.04
六、净利润35,626,216.6117,693,420.3467,022,088.6755,980,653.05
(一)按经营持续性分类
  持续经营净利润35,626,216.6117,693,420.3467,022,088.6755,980,653.05
(二)按所有权归属分类
  归属于母公司股东的净利润35,626,216.6117,693,420.3467,022,088.6755,980,653.05
  扣除非经常损益后的净利润35,025,132.5316,104,648.5157,166,092.3446,894,397.37
七、每股收益
  (一)基本每股收益0.260.130.490.41
  (二)稀释每股收益0.260.130.490.41
八、其他综合收益-1,654,601.841,384,283.7-8,520,753.52-2,870,719.32
  归属于母公司股东的其他综合收益-1,654,601.841,384,283.7-8,520,753.52-2,870,719.32
九、综合收益总额33,971,614.7719,077,704.0458,501,335.1553,109,933.73
  归属于母公司股东的综合收益总额33,971,614.7719,077,704.0458,501,335.1553,109,933.73
公告日期2026-08-242026-04-282026-04-282025-10-29
审计意见(境内)标准无保留意见
TOP↑